Should states launch clinical trials for repurposed drugs that may help treat cancers?
15 votes|10 arguments|0 source
Off-patent drugs with promising signals are abandoned because no company can profit. Public trials are the only way to evaluate them rigorously. @@yes_1
Quasi-experimental study exploiting staggered platform rollouts across US universities.
Comparative overview of how surrogacy is regulated across 46 European jurisdictions, from outright bans to fully commercial frameworks.
Estimation annuelle de la mortalité attribuable aux particules fines (PM2.5) à l'échelle des aires urbaines.
Meta-analysis of 28 studies on physical and psychological outcomes for gestational surrogates and the children they carry.